ACLU (American Civil Liberties Union). 1996a. ACLU condemns governor for signing mandatory chemical castration law. ACLU Press Release, Tuesday, September 17, 1996.
3.
ACLU (American Civil Liberties Union). 1996b. Chemical castration law may backfire, experts warn. ACLU Press Release, Wednesday, September 18, 1996.
4.
AlvaradoD.1996. Chemical castration in effect: Warning: As Wilson signs the law, an expert says it could backfire. Mercury Center. Database on-line. Available from http://www.sjmercury.com/reprints/castr918.htm.
5.
American Medical Association. 1996. Code of medical ethics: Current opinions and annotations. Washington, DC: American Medical Association Council on Ethical and Judicial Affairs.
6.
American Psychological Association. 1992. Ethical principles of psychologists and code of conduct. American Psychologist47: 1597–1611.
7.
AppletonL. M.1995. Rethinking medicalization: Alcoholism and anomalies. In Images of issues: Typifying contemporary social problems, ed. BestJ., 59–80. New York: Aldine de Gruyter.
ATSA (Association for the Treatment of Sexual Abusers). 1997. Anti-androgen therapy and surgical castration: Adopted by the ADSA Executive Board of Directors on February 7, 1997. Database on-line. Available from http://www.atsa.com/pages/policy/anti.html.
10.
BakerK. K.1997. Once a rapist? Motivational evidence and relevancy in rape law. Harvard Law Review110: 563–624.
11.
BancroftJ.TennentG.LoucasK.. 1974. “The control of deviant sexual behaviour by drugs.”British Journal of Psychiatry125: 310–315.
BerlinF. S.1997. Chemical castration for sex offenders. The New England Journal of Medicine336:1030.
14.
BerlinF. S.MeineckeC. F.. 1981. Treatment of sex offenders with antiandrogenic medication: Conceptualization, review of treatment modalities, and preliminary findings. American Journal of Psychiatry138: 601–607.
15.
BonsallR. W.ReesH. D.MichaelR. P.. 1990. Uptake of Medroxyprogesterone Acetate by Progestin and Androgen target neurons in the brain and pituitary gland of male cynomolgus monkeys. Neuroendocrinology52: 573–580.
16.
BradfordJ. M. W.1988. Organic treatment for the male sex offender. Annals of the New York Academy of Sciences 193–202.
17.
BradfordJ. M. W.1990. The antiandrogen and hormonal treatment of sex offenders. In Handbook of sexual assault: Issues, theories, and treatment of the sex offender, eds. MarshallW. L.LawsD. R.BarbareeH. E., 297–310. New York: Plenum Press.
18.
BradfordJ.McDW.PawlakA.. 1987. Sadistic homosexual pedophilia: Treatment with Cyproterone Acetate: A single case study. Canadian Journal of Psychiatry32: 22–30.
19.
BradfordJ.McDW.PawlakA.. 1993. Effects of Cyproterone Acetate on sexual arousal patterns of pedophiles. Archives of Sexual Behavior22: 629–641.
20.
BrodyA. L.GreenR.. 1994. Washington State's unscientific approach to the problem of repeat sex offenders. Bulletin of the American Academy of Psychiatry and the Law22: 343–356.
ColemanE.CesnikJ.MooreA.DwyerS. M.. 1992. An exploratory study of the role of psychotropic medications in the treatment of sex offenders. Journal of Offender Rehabilitation18: 75–88.
29.
ConradP.1975. The discovery of Hyperkinesis. Notes on the medicalization of deviant behavior. Social Problems23: 12–21.
30.
ConradP.SchneiderJ. W.. 1980. Deviance and medicalization: From badness to sickness. St. Louis: Mosby.
31.
ConstantM.AbramsC. A. L.ChasalowF. I.. 1993. Gonadatropin-associated psychosis in perimenstrual behavioral disorder. Hormonal Research40: 141–144.
32.
Contraceptive Technology. 1996. Contraceptive Technology. New York: Irvinton Publishers Inc.
33.
CooperA. J.IsmailA.A.A.PhanjooA. L.LoveD. L.. 1972. Androgen (Cyproterone Acetate) therapy in deviant hypersexuality. British Journal of Psychiatry120: 59–63.
34.
CooperA. J.1981. A placebo-controlled trial of the Antiandrogen Cyproterone Acetate in deviant hypersexuality. Comprehensive Psychiatry22: 458–465.
35.
CooperA. J.1986. Progestogens in the treatment of male sex offenders: A review. Canadian Journal of psychiatry31: 73–79.
36.
CooperA. J.SandhuS.LosztynS.CemovskyZ.. 1992. A double-blind placebo controlled trial of Medroxyprogesterone Acetate and Cyproterone Acetate with seven pedophiles. Canadian Journal of Psychiatry37: 687–693.
37.
CordobaO.A.ChapelJ. L.. 1983. Medroxyprogesterone Acetate Antiandrogen treatment of hypersexuality in a pedophiliac offender. American Journal of Psychiatry140: 1036–1039.
FedoroffJ. PaulFedoroffI. C.. 1992. Busiprone and paraphilic sexual behavior. Journal of Offender Rehabilitation18: 89–108.
44.
FitzgeraldE. A.1990. Chemical castration: MPA treatment of the sexual offender. American Journal of Criminal Law18: 1–60.
45.
Freeman-LongoR. E.1996. Feel good legislation: Prevention of calamity. Child Abuse & Neglect20: 95–101.
46.
GagneP.1981. Treatment of sex offenders with Medroxyprogesterone Acetate. American Journal of Psychiatry138: 644–646.
47.
GinzbergJ. F.1992. Compulsory contraception as a condition of probation: The use and abuse of Norplant. Brooklyn Law Review58: 979–1019.
48.
GottesmanH. G.SchubertD. S. P.. 1993. Low-dose oral Medroxyprogesterone Acetate in the management of paraphilias. Journal of Clinical Psychiatry54: 182–188.
49.
GreenfeldL. A.1997. Sexual offenses and offenders: An analysis of data on rape and sexual assault. Washington, DC: The BJS Clearinghouse, U. S. Department of Justice, Office of Justice Programs, Bureau of Justice Statistics. Database on-line. Available from http://www.ojp.usdoj.gov/bjs.
50.
GrossmanL. S.1985. Research directions in the evaluation and treatment of sex offenders: An analysis. Behavioral Sciences & the Law3: 421–440.
51.
HallG. C. N.1995. Sexual offender recidivism revisited: A meta-analysis of recent treatment studies. Journal of Consulting and Clinical Psychology63: 802–809.
52.
Harvard Law Review. 1997. Recent Legislation. Harvard Law Review110: 799–804.
HermanJ. L.1990. Sex offenders: A feminist perspective. In Handbook of Sexual Assault, ed. MarshallW. L.LawsD. R.BarbareeH. E., 177–193. New York: Plenum Press.
55.
KierschT. A.1990. Treatment of sex offenders with Depo-Provera. Bulletin of the American Academy of Psychiatry and the Law18: 179–187.
LacayoR.1992. Sentence inscribed on flesh. Time Magazine139(12): 54 & 59.
60.
LaschetU.LaschetL.. 1975. Antiandrogens in the treatment of sexual deviations in men. Journal of Steroid Biochemistry6: 821–826.
61.
LewisM.1997. California, ESQ. The new castration. California Lawyer17(1): 21.
62.
LyngStephen1997. Social problems research and civic discourse. Humanity & Society21: 162–181.
63.
MelellaJ. T.TravinS.CullenK.. 1989. Legal and ethical issues in the use of Antiandrogens in treating sex offenders. Bulletin of the American Academy of Psychiatry and Law17: 223–232.
64.
MeyerW. J.ColeC.EmoryE.. 1992. Depo-Provera treatment for sex offending behavior: An evaluation of outcome. Bulletin of the American Academy of Psychiatry and the Law20: 249–259.
65.
MeyerW. J.WalkerP. A.EmoryL. E.SmithE. R.. 1985. Physical, metabolic, and hormonal effects on men of long-term therapy with Medroxyprogesterone Acetate. Fertility and Sterility43: 102–109.
66.
MichaelR. P.BonsallR. W.ZumpeD.. 1991. Medroxyprogesterone Acetate and the nuclear uptake of Testosterone and its metabolites by brain, pituitary gland and genital tract in male Cynomolgus monkeys. Journal of Steroid Biochemistry and Molecular Biology38: 49–57.
67.
MichaelR. P. D.Zumpe. 1993. Medroxyprogesterone Acetate decreases the sexual activity of male Cynomolgus monkeys (Macaca fascicularis): An action on the brain?Physiology and Behavior53: 783–788.
68.
MoneyJ.1987. Treatment guidelines: Antiandrogen and counseling of paraphilic sex offenders. Journal of Sex and Marital Therapy13: 219–223.
69.
MurrayJ. B.1988. Psychopharmacological therapy of deviant sexual behavior. The Journal of General Psychology115 (1): 101–110.
70.
OliverioA.LauderdaleP.. 1996. Therapeutic states and attention deficits: Differentional cross-national diagnostics and treatments. International Journal of Politics, Culture and Society10: 355–73.
71.
RadaR. T.1980. Plasma Androgen and the sex offender. Bulletin of the American Academy of Psychiatry and the Law8: 456–464.
72.
RichardM. M.1996. CH. A. D. D. response on International narcotics control board annual report. An open letter on the web to the U. N. International Narcotics Control Board. Database on-line. Available from http://www.chadd.org/incbresp.htm.
73.
RothmanB. K.1995. Of maps and imaginations: Sociology confronts the genome. Social Problems42: 1–10.
74.
RoyceEdward1996. The public intellectual. Humanity & Society20: 3–17.
75.
SalterA. C.1995. Transforming trauma: A guide to understanding and treating adult survivors of child sexual abuse. Thousand Oaks, CA: Sage.
SpodakM. K.FalckZ. A.RappeportJ. R.. 1978. The hormonal treatment of paraphiliacs with Depo-Provera. Criminal Justice and Behavior5: 304–332.
80.
TancrediL. R.WeisstubD. N.. 1986. Technology assessment: Its role in forensic psychiatry and the case of chemical castration. International Journal of Law and Psychiatry8: 257–271.
81.
TsangD. C.1995. Policing perversions: Depo-Provera and John Money's new sexual order. Journal of Homosexuality28: 397–426.
82.
VachhsA.1992. Sex offenders: Is castration an acceptable punishment? No: Pragmatically impotent. ABA Journal78:43.
83.
Van BiemaD.1996. A cheap shot at pedophilia? California mandates chemical castration for repeat child molesters. Time Magazine148(12): 60.
VanderzylK. A.1994. Castration as an alternative to incarceration: An impotent approach to the punishment of sex offenders. Northern Illinois University Law Review15: 107–140.
86.
WalkerP.MeyerW.. 1981. Medroxyprogesterone Acetate treatment for paraphiliac sex offenders. In Violence and the violent individual, ed. HayesH. R.RobertsT. K.SolowayK. S.. Spectrum Publications: Jamaica, NY.
87.
WinczeJ. P.BansalS.MalamudM.. 1986. Effects of Medroxyprogesterone Acetate on subjective arousal, arousal to erotic stimulation, and nocturnal penile tumescence in male sex offenders. Archives of Sexual Behavior15: 293–305.
YoungI. M.1990. Justice and the politics of difference. Princeton: Princeton University Press.
91.
ZumpeD.BonsallR. W.KutnerM. H.MichaelR. P.. 1991. Medroxyprogesterone Acetate, aggression, and sexual behavior in male Cynomolgus Monkeys. Hormones and Behavior25: 394–409.
92.
ZumpeD.ClancyA. N.BonsallR. W.MichaelR. P.. 1996. Behavioral responses to Depo-Provera, Fadrozole, and Estradiol in castrated, Testosterone-treated Cynomolgus Monkeys (Macaca fascicularis): The involvement of Progestin receptors. Physiology and Behavior60: 531–540.
93.
ZumpeD.MichaelR. P.. 1988. Effects of Medroxyprogesterone Acetate on plasma Testosterone and sexual behavior in male Cynomolgus Monkeys (Macaca fascicularis). Physiology and Behavior42: 343–349.